Trials / Completed
CompletedNCT02897492
Rapid and Highly Sensitive Detection of Fluorescently-labeled Troponin in Patients Admitted With Chest Pain
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- Rambam Health Care Campus · Academic / Other
- Sex
- All
- Age
- 18 Years – 120 Years
- Healthy volunteers
- Accepted
Summary
Patients with chest pain may have postponed or missed diagnosis of acute coronary events due to relatively late detection of troponin elevation. The study will investigate a new diagnostic method for early detection of even minimal troponin elevation in patients admitted with chest pain.
Detailed description
Patients with chest pain may have postponed or missed diagnosis of acute coronary events due to relatively late detection of troponin elevation. The study will investigate a new diagnostic method for early detection of even minimal troponin elevation in patients admitted with chest pain. A new diagnostic method will be applicated in the recent studies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Blood testing in a newly described method | To exploit detection strategy termed "Magnetic Modulation Biosensing", or MMB) to develop a novel, low-cost platform that can detect biomarkers, such as proteins and specific DNA sequences, rapidly and directly from real samples at very low concentrations. |
Timeline
- Start date
- 2016-09-01
- Primary completion
- 2019-03-01
- Completion
- 2019-03-20
- First posted
- 2016-09-13
- Last updated
- 2019-03-28
Source: ClinicalTrials.gov record NCT02897492. Inclusion in this directory is not an endorsement.